Abbott

Abbott's most recent disclosed emissions data for 2025 indicates total Scope 1 emissions of approximately 499,000,000 kg CO2e and Scope 2 emissions of about 350,000,000 kg CO2e. Their Scope 3 emissions for the same year include approximately 3,835,000,000 kg CO2e from purchased goods and services, 800,000,000 kg CO2e from upstream transportation and distribution, 562,000,000 kg CO2e from use of sold products, 253,000,000 kg CO2e from employee commute, 236,000,000 kg CO2e from capital goods, 215,000,000 kg CO2e from fuel and energy-related activities, 168,000,000 kg CO2e from business travel, and 86,000,000 kg CO2e from end-of-life treatment of sold products, along with 7,000,000 kg CO2e from waste generated in operations.

Abbott has set a near-term target, validated by the Science Based Targets initiative (SBTi) and classified as "Well-below 2°C", to reduce absolute Scope 1 and 2 GHG emissions by 30% by 2030, using a 2018 baseline. Additionally, Abbott commits that 82% of its suppliers, by emissions covering purchased goods and services and upstream transportation and distribution, will have science-based targets by 2026. Abbott Laboratories Ltd., a UK subsidiary of Abbott, is committed to achieving Net Zero emissions by 2050 across all scopes.

Historically, Abbott had a 2020 target to reduce its Scope 1 and 2 emissions by 40% against 2010 levels, adjusted for sales, and exceeded this target by achieving a 43% reduction in 2019. The company also aims to reduce its Scope 1 and Scope 2 emissions to near zero by 2025. All disclosed climate data and commitments are directly from Abbott Laboratories.